MoonLake Immunotherapeutics
NASDAQMLTX short interest jumps 23.2% in one week to 9.4% of free float, driven by recent insider selling and strong stock momentum amid clinical-stage biotech volatility.
Snapshot as of 9 Aug 2026
MoonLake Immunotherapeutics ends the week in retreat — down 8.2% to $19.47 — with insiders still distributing stock and the extreme options bullishness flagged last week having quietly unwound. The insider selling is…
MoonLake Immunotherapeutics heads into the week with a sharp contradiction at its core: options traders are the most bullish they have been all year, while the founders and CFO have been selling stock steadily into the…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for MLTX — free to start on ORTEX.
Sign up for free →Open MLTX on ORTEX